Boston Scientific’s EP leaders Stein and Spadea-Anello discuss the next leap in cardiac ablation

In this episode of Boston Scientific Talks, Boston Scientific’s electrophysiology leaders, Ken Stein, MD, SVP, Global Chief Medical Officer and Nick Spadea-Anello, Global President of Electrophysiology, offer a deep dive into the transformative potential of the FARAPULSE Pulsed Field Ablation System. They discuss the strategic development and clinical advantages of this innovative technology, emphasizing its ability to target cardiac tissue while minimizing the risk of collateral damage to vital structures like the esophagus.

The duo also explores the synergistic potential of combining PFA with devices like the WATCHMAN for stroke prevention, painting a picture of a more streamlined, patient-centric approach to cardiac care. With a keen eye on the future, they discuss the vision for expanding PFA’s applications, including its role in treating a broader spectrum of arrhythmias and its adaptability to various procedural settings. Tune in to learn more about Boston Scientific’s forward-thinking approach to cardiac ablation.

Thank you to Dassault Systèmes for sponsoring this episode. To learn how Dassault Systèmes enables innovation in medtech, visit www.medtecheco.com/lifecycle. 

Thank you for listening to the Boston Scientific Podcast.

Subscribe to this podcast on every major podcast platform.